Versant Capital Management »

Keros Therapeutics shares owned by Versant Capital Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $342 31 11.03
2025-03-31 $6.6k 643 10.19

More positions owned by Versant Capital Management

Microsoft Stock (MSFT)
Avantis International Equity Etf Etf (AVDE)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Ishares S&p Global Energy Etf (IXC)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Apple Stock (AAPL)
Avago Technologies Stock (AVGO)
Nvidia Corp Stock (NVDA)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)
Vanguard Total Stk Mkt Etf (VTI)
State Street Spdr S&p Global Natural Resources Etf Etf (GNR)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)

View all positions for Versant Capital Management

Top funds holding Keros Therapeutics

BlackRock
Vanguard Group
Nantahala Capital Management
Arrowstreet Capital, Limited Partnership
State Street Corporation
Vanguard Capital Management
Madison Avenue Partners
Qube Research & Technologies
OrbiMed Advisors
Jacobs Levy Equity Management
Federated Investors
Vanguard Portfolio Management
Geode Capital Management
Renaissance Technologies
Citadel Advisors

View all funds holding Keros Therapeutics